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Mounting evidence suggests that PERIOD (PER) proteins play a
central role in setting the speed (period) and phase of the circadian
clock. Pharmacological andgenetic studies have shown that changes
in PER phosphorylation kinetics are associated with changes in
circadian rhythmperiodandphase,which can lead to sleepdisorders
such as Familial Advanced Sleep Phase Syndrome in humans. We
and others have shown that casein kinase 1δ and ε (CK1δ/ε) are
essential PER kinases, but it is clear that additional, unknownmech-
anisms are also crucial for regulating the kinetics of PER phosphor-
ylation. Here we report that circadian periodicity is determined
primarily through PER phosphorylation kinetics set by the balance
between CK1δ/ε and protein phosphatase 1 (PP1). In CK1δ/ε-deﬁ-
cient cells, PER phosphorylation is severely compromised and non-
rhythmic, and the PER proteins are constitutively cytoplasmic.
However, when PP1 is disrupted, PER phosphorylation is dramati-
cally accelerated; the sameeffect is not seenwhenPP2A is disrupted.
Ourwork demonstrates that the speed and rhythmicity of PER phos-
phorylation are controlled by the balance between CK1δ/ε and PP1,
which in turn determines the period of the circadian oscillator. Thus,
our ﬁndings provide clear insights into the molecular basis of how
the period and phase of our daily rhythms are determined.
dynamic regulation of phosphorylation | stoichiometry |
period determination
The circadian clock controls so much of mammalian physiologythat dysregulation of the clock contributes to medical con-
ditions such as jet lag, shift work sleep disorder, metabolic dis-
eases, and mood disorders (1, 2). In most of the body’s cells, from
the neurons of the suprachiasmatic nucleus (SCN) to hepatocytes,
lung epithelial cells, and even ﬁbroblasts, the clock is present and
its molecular mechanism is essentially the same (3–6). The back-
bone of the oscillator mechanism is a transcriptional negative
feedback loop driven by positive and negative elements (7–10).
The positive elements are three bHLH/PAS-containing tran-
scription factors, CLOCK, NPAS2, and BMAL1; the CLOCK (or
NPAS2):BMAL1 heterodimer binds to E-box enhancer motifs
and activates transcription of the negative element genes,Per1 and
2, andCryptochrome (Cry)1 and 2. The PER:CRYcomplexes com-
plete the feedback loop by inhibiting CLOCK:BMAL1.
Although all of these clock proteins are essential, PERIOD
(PER) is of special importance for clock regulation. PER is the
rate-limiting component for PER:CRY complex formation, and
thus the timing and duration of PER nuclear entry and accumu-
lation dictate the phase and period of themolecular clock (11–13).
Of all of the core clock proteins, only PER’s expression is abso-
lutely required to oscillate for the clock to function; constitutive
high expression of PER completely disrupts circadian rhythms in
cells and mice (11). Phosphorylation of PER is a vital part of clock
regulation, as it affects PER’s nuclear translocation, interaction
with other clock proteins, and timely degradation (14–18). In vivo,
PER phosphorylation—detectable as a mobility shift in SDS/
PAGE—occurs progressively over several hours (12, 19), which is
critical for stretching the feedback loop to ∼24 h. However, PER2
can be maximally phosphorylated by CK1ε in vitro kinase reac-
tions within 30 min (20, 21), suggesting that PER phosphorylation
must be counterbalanced by phosphatases in vivo.
Because the phase and period of the clock are primarily de-
termined by temporal regulation of PER phosphorylation (12, 15,
21–26), the characterization of PER kinases and phosphatases is
vital to understanding the circadian clock mechanism. CK1δ and ε
have been shown to be PER kinases and are important for clock
function, but PER phosphorylation is largely intact in several
CK1δ or CK1εmutants (12, 21, 23, 27). Furthermore, PER can be
phosphorylated by several other kinases in vitro, including CK1α
and γ, CK2, and GSK3β (28–32). Thus, it remains unclear which
kinases are responsible for the majority of mobility-shifting, pro-
gressive phosphorylation of PER in vivo. In this study, we show
that CK1δ and ε are the major PER kinases and that they are
largely redundant with each other, such that PER phosphorylation
and the circadian clock’s function can endure the loss of just one
kinase. Moreover, we identify PP1 as the major PER phosphatase
that counterbalances CK1δ/ε and other PER kinases in vivo.
Results
PER Phosporylation Is Severely Compromised and the Molecular Clock
Is Not Functional in CK1δ/ε-Deﬁcient Fibroblasts. We previously
provided evidence for the importance of CK1δ/ε for clock function
by combining CK1δ gene deﬁciency with dominant negative CK1ε
expression (21). However, the dominant negative CK1ε may have
interfered not only with wild-type CK1ε (wtCK1ε) activity, but also
with other isoforms of CK1 as suggested by Hirota et al. (29). To
deﬁnitively test how CK1δ/ε contribute to temporal PER phos-
phorylation in vivo, we assessed circadian rhythms and the molec-
ular clock in mouse ﬁbroblasts deﬁcient in both CK1δ and ε.
Because CK1δ deletion results in embryonic lethality, we derived
the ﬁbroblasts from mice with ﬂoxed CK1δ/ε genes, so that the
genes could be deleted conditionally using the Cre-loxP recom-
bination system (27). Cre recombinase was expressed using an
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adenoviral vector (11). Neither adenoviral infection nor Cre ex-
pression affected circadian rhythms in WT cells (Fig. S1). In the
double-ﬂoxedmutant cells,CK1δ and εwere both deleted in almost
100% of cells within 4 d after the adenoviral cre infection, as con-
ﬁrmed by genotyping PCR (Fig. S2) and immunoblots (Fig. 1A).
When the double-ﬂoxed mutant cells were infected with ade-
noviral gfp, PER phosphorylation remained rhythmic and was
followed by degradation (Fig. 1B, Left four lanes), similar to WT
cells (13, 21). However, when CK1δ/ε were disrupted by ade-
noviral cre, PER rhythms in abundance and phosphorylation
were completely abolished (Fig. 1B, Right four lanes). Further-
more, phosphorylation levels were dramatically reduced, with
PER2 showing no mobility shift, whereas PER1 exhibited only
half the mobility shift of PER1 in control cells (Fig. 1 B and C;
see Fig. 2B for side-by-side comparison). PER1 protein levels in
CK1δ/ε-null cells were similar to peak levels in control cells,
whereas PER2 levels were somewhat lower than peak levels.
Considering the low Per mRNA levels in the double-mutant cells
(Fig. S3), these protein levels suggest that PER1 and PER2 are
more stable in the mutant cells.
Our ﬁndings are further supportedwhen degradation rates were
measured after the cells were treated with cycloheximide. Both
PER1 and PER2 were signiﬁcantly more stable in the mutant
cells compared with control cells (Fig. 1D). Nonphosphorylated
CLOCK was also more pronounced in the mutant cells (Fig. 1B),
which suggests that CLOCK is also a substrate of CK1δ/ε, likely
via CK1δ/ε:PER complexes. This ﬁnding is reminiscent of what
has been found in Neurospora and Drosophila (33–36).
Deletion of CK1δ/ε also caused PER1 and PER2 to accumu-
late predominantly in the cytoplasm, whereas they were mostly
nuclear in control cells (Fig. 2A and Fig. S4 A and B). These
results suggest that PER phosphorylation is required for nuclear
translocation or accumulation, as has been reported in Dro-
sophila (37). Our ﬁndings are consistent with data obtained from
liver tissue, where hypophosphorylated PER species are cyto-
plasmic and not complexed with CK1δ/ε (12).
Because previous research suggested that hyperphosphorylation
targets PER for proteasomal degradation (22, 28, 38), we con-
sidered the possibility that the lack of hyperphosphorylated, nu-
clear PER1/2 may have been due to rapid degradation as opposed
to reduced phosphorylation and lack of nuclear transport. To test
this possibility, we treated the cells with a mixture of proteasome
inhibitors (MG132 + PSI + lactacystin). In control cells, in-
hibition of proteasomal degradation increased levels of hyper-
phosphorylated PER1 and both hypo- and hyperphosphorylated
PER2 levels, consistent with previous work (Fig. 2B) (21). The
same treatment in the CK1δ/ε-deﬁcient cells did not result in the
detection of hyperphosphorylated forms, demonstrating that
elimination of CK1δ/ε does prevent a substantial amount of PER
phosphorylation. However, the treatment induced accumulation
of hypophosphorylated PER in the CK1δ/ε-deﬁcient cells, albeit
at a slower rate than in control cells (Fig. 2B), consistent with the
data in Fig. 1D. Thus, though CK1δ/ε are essential for PER nu-
clear transport and regulate PER degradation, PER can still be
targeted for proteasomal degradation in the absence of CK1δ/ε.
As loss of CK1δ/ε disrupts rhythms in PER abundance and
nuclear transport, it also disrupts bioluminescence rhythms mea-
sured using a Per2 promoter-driven luciferase reporter (Fig. 2C
and Fig. S4C andD). Similar results were obtainedwith lung tissue
explants after CK1δ/ε genes were deleted by adenoviral cre (Fig.
2D and Fig. S4E). The defects in PER phosphorylation and
rhythmicity were readily rescued by exogenous expression ofCK1ε
in the mutant cells, indicating that the circadian defects were not
due to general damage to cell physiology in themutant cells caused
by kinase deﬁciency or by the adenoviral cre vector (Fig. 2 C and E
and Fig. S4F). The period was signiﬁcantly shorter in CK1δ/ε
mutant cells expressing transgenic CK1ε, probably due to over-
expression of the transgenic CK1ε relative to endogenous CK1δ/ε
(Fig. 2E) (21). This dose-dependent effect of CK1δ/ε on period
length is further supported by a dramatic period lengthening
observed inCK1δΔ2/Δ2:CK1ε−/+ cells where only one allele ofCK1ε
is preserved (Fig. S4G). The period was lengthened by ∼2.5 h
relative to WT cells, or ∼1 h relative to CK1δΔ2/Δ2:CK1ε+/+ cells
(27). The single-copy CK1ε cells were generated by expressing Cre
in CK1δﬂ/ﬂ:CK1ε ﬂ/+ cells. PER1/PER2 phosphorylation was
completely rescued by exogenous expression of wtCK1ε but not
by a dominant negative CK1ε (DNCK1ε; Fig. 2E). Interestingly,
expression of DNCK1ε increased levels of PER1/2 in the mutant
cells, suggesting that DNCK1ε may interfere with targeted deg-
radation of PER even in the absence of endogenous CK1δ/ε.
Inhibition of Protein Phosphatases by Calyculin A Induces Rapid
Hyperphosphorylation of PER and Shortened Circadian Periods. The
slow and progressive PER phosphorylation seen in vivo, in contrast
to the rapid PER phosphorylation seen in an in vitro kinase assay
(21), may be attributed to either down-regulation of CK1δ/ε en-
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Fig. 1. PER1/2 do not oscillate, and their phosphorylation is severely com-
promised in CK1 double-mutant (CK1δΔ2/Δ2:CK1ε−/−) ﬁbroblasts. (A) CK1δ and ε
were successfully deleted by introducing adenoviral cre into the double-
ﬂoxed mutant cells. Cells were harvested 3 and 4 d after adenoviral cre or gfp
infection, and then subjected to immunoblotting for CK1δ/ε and ACTIN. Note
that a small band—indicated by the arrow and representing a deletion mu-
tant, inactive form of CK1δ—is present, as reported by Etchegaray et al. (27).
The arrowhead indicates a nonspeciﬁc band (NS). (B) PER does not oscillate in
CK1δ/ε double-mutant cells. Cells were infected with adenoviral cre or gfp and
harvested 5–6 d later at the indicated times after a 2-h serum shock. It is
shown that two phosphorylated CLOCK isoforms are derived from two non-
phosphorylated isoforms (indicated by asterisks) in ﬁbroblasts as previously
reported in liver (13). (C) PER1 is still phosphorylated, but PER2 is not appar-
ently phosphorylated in the double-mutant cells. Immunoprecipitated PER1/2
from the double-mutant cells were subjected to λ-phosphatase (λ-Pase) re-
action to reveal any mobility shift due to phosphorylation, as done previously
(12). Vanadate, a phosphatase inhibitor, prevents the change in PER1 mobil-
ity. (D) PER1/2 are more stable in CK1δ/ε-deﬁcient cells. The control and mu-
tant cells were treated with CHX and harvested at the indicated times for
immunoblotting assays. (Right) Results quantiﬁed by densitometric scanning.
Values shown are mean ± SEM from four independent experiments. P values
were calculated by Student t test between two groups. *P < 0.05; **P < 0.01.
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zyme activity or a counterbalancing of PER phosphorylation by
phosphatases. Although the enzyme activity of CK1δ/ε can be
down-regulated by autophosphorylation in vitro, we have not ob-
served such autophosphorylated isoforms for CK1δ/ε in ﬁbroblasts
or tissues in vivo (12, 21). Moreover, because protein phosphatases
PP1 and PP2A have been implicated as clock components in
various model organisms (39–43), we focused on the hypothesis
that one or both of these two phosphatases are important for
regulating progressive PER phosphorylation in mammals.
To test our hypothesis, we evaluated how phosphatase inhibitors,
okadaic acid (OA) and calyculin A (CA), affect circadian rhythms
in Per2Luc ﬁbroblasts and lung explants (4). Because both OA and
CA have cytotoxic effects, we could measure bioluminescence
rhythms for only a couple of days after the drug treatment. When
Per2Luc cells were treated with OA, bioluminescence rhythms and
PER phosphorylation were not signiﬁcantly altered (Fig. 3A and
Fig. S5A). However, the rhythms were immediately abolished by
treatment with CA (Fig. 3A), which is a much more potent PP1
inhibitor than OA (44). At lower doses, CA treatment induced
shortened periods in a dose-dependent manner (Fig. 3B and Fig.
S5B). All CA treatment conditions (continuous incubation or short
incubation followed by wash-off) that signiﬁcantly shortened the
circadian period also caused cell death and allowed only one cycle
after the CA treatment. Despite numerous efforts, we could not
ﬁnd conditions that induced short periods without causing cell
death, suggesting that cell death is induced at lower doses than
those affecting circadian rhythms. Immunoblots revealed striking
effects of CA on endogenous PER. PER1 and PER2 from CA-
treated cells migratedmuchmore slowly compared with those from
control and OA-treated cells, and these isoforms were hyper-
phosphorylated (Fig. 3C and Fig. S5C). The unusually hyper-
phosphorylated PER isoforms seem to be very unstable, as they
have not been seen previously in vivo and they disappeared rapidly.
Indeed, they were stabilized when the CA cells were treated with
the proteasome inhibitor mixture (Fig. S5D).
For a more quantitative assessment, we assessed PER phos-
phorylation rate from de novo synthesized proteins after existing
PER proteins were depleted by cycloheximide treatment. Under
normal conditions, PER1 and PER2 reached their maximum
phosphorylation state (lowest mobility form) between 3 and 6 h
after cycloheximide removal (Fig. 3D). However, PER achieved an
even slower mobility form (extrahyperphosphorylated state) in <1.5
h in CA-treated cells. PER was similarly extrahyperphosphorylated
within 30 min when PER:CK1δ/ε complexes were puriﬁed from
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Fig. 2. PER1/2 are predominantly cytoplasmic, and circadian rhythms are completely disrupted in CK1δ/ε-deﬁcient cells. (A) PER1/2 fail to accumulate in the
nucleus in the double-mutant cells. The double-ﬂoxed mutant cells were infected with adenoviral cre or gfp, given a 2-h serum shock 5 d later, and immu-
nostained for PER1/2 at 24 h after the serum shock. More cells are shown in Fig. S4A and B. (B) Lack of hyperphosphorylated species of PER is not due to reduced
stability of these species in the mutant cells. PER levels are increased in both control (GFP) and mutant (Cre) cells by proteasome inhibitor mixture treatment.
Cells were harvested at the indicated times after the drug treatment. Blots are representative of several experiments. (C) Circadian rhythms are disrupted in the
mutant cells and tissue but can be readily rescued by exogenous expression of wtCK1ε. Bioluminescence rhythms were measured by infecting the adenoviral
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is also rescued in the mutant cells by exogenous expression of wtCK1ε, but not by a dominant negative mutant CK1ε (DNCK1ε). Adenoviral gfp, wtCK1ε, or
DNCK1ε was infected into control and mutant cells. Two exposures (long and short) are shown for the CK1ε immunoblot.
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cell extracts and incubated in vitro with ATP, suggesting that CK1δ/
ε and/or other copuriﬁed kinases can phosphorylate PER rapidly
in vitro to a level similar to that seen in CA-treated cells (Fig. 3E).
Consistent with previous ﬁndings (45), CK1δ/ε were also phos-
phorylated under these conditions. CA treatment also allowed the
accumulation of hyperphosphorylated CK1δ/ε, suggesting that
CK1δ/ε, like PER, are dephosphorylated by phosphatases in vivo,
and that phosphorylation promotes degradation (Fig. S6) (45).
PP1 Is a Major Phosphatase That Counteracts PER Kinases to Ensure
That PER Phosphorylation Occurs Gradually During the Circadian
Cycle. The difference in the effects of the two phosphatase
inhibitors on PER phosphorylation state and bioluminescence
rhythms is informative. OA inhibits PP2A with >100-fold greater
potency than PP1, and our dose was >2 orders of magnitude
higher than the IC50 for PP2A; these results suggest that inhibition
of PP2A does not affect the circadian period. In contrast, CA
inhibits PP1 and PP2A with almost equal potency (44). Thus, our
results suggest that PP1 plays a critical role in the mammalian
clock mechanism. To test by a nonpharmacological approach
whether PP2A plays a signiﬁcant role in PER dephosphorylation
and in circadian clock function, we used mouse embryonic ﬁbro-
blasts (MEFs) derived from the α4 mutant mouse in which PP2A
activity is severely compromised (>70%). α4 is a regulatory pro-
tein that binds to and regulates the activity and/or stability of the
major phosphatases, PP2A, PP4, and PP6 (46–49). Although α4
deletion usually leads to immediate cell death, the p53−/− back-
ground renders the mutant cells viable (48). We measured PER
phosphorylation in α4ﬂp53−/− cre-ER MEFs where α4 is condi-
tionally deleted by 4-hydroxy-tamoxifen treatment. As reported by
Kong et al. (48), levels of α4 and PP2Ac were dramatically re-
duced in the cells 6 d after 4-hydroxy-tamoxifen treatment (Fig.
4A). PER levels were slightly reduced, but phosphorylation levels
were not signiﬁcantly altered, indicating that PP2A, PP4, and PP6
do not play a major role in dephosphorylating PER.
Furthermore, we found that PP1 coimmunoprecipitates with
PER in vivo, as CK1δ and CK1ε do, although the PP1/PER in-
teraction seems to be signiﬁcantly weaker than that between PER
and CK1δ/ε (Fig. 4B). Interestingly, coimmunoprecipitated PER
wasmid- to hyperphosphorylated, suggesting that these species have
higher afﬁnity for PP1 than non- or hypophosphorylated species.
We then speciﬁcally disrupted PP1 activity using dominant negative
mutants of PP1. Like PP2A, PP1 cannot be constitutively disrupted
due to its essential role in cell physiology (50, 51). We generated
inducible adenoviral vectors to express two different dominant
negative PP1 mutants (DN64 and DN95) (52) in a doxycycline
(Dox)-dependent manner. These DNmutants induced cell death in
rapidly growing cells, consistent with signiﬁcant interference with
endogenous PP1 activity. However, quiescent cells in serum-free
medium could tolerate the DN mutants, and we normally measure
circadian rhythms under these conditions. When expression of ei-
ther PP1 mutant was induced by Dox, bioluminescence rhythms
were severely disrupted and basal levels of bioluminescence were
lowered (Fig. 4C). Further, consistent with accelerated PER phos-
phorylation, the period (measured between the ﬁrst two peaks) was
dramatically shortened (3–4 h) compared with that of control cells.
However, a normal period was readily restored when Dox was
washed off, indicating that period shortening was caused by the
reversible inhibition of PP1 activity, probably on PER rather than
cytotoxic effects of PP1 inhibition (Fig. S7A). In desynchronized
cells following Dox treatment, PER1 and PER2 were progressively
hyperphosphorylated and disappeared (Fig. 4D), indicating that
PP1 is a major phosphatase counteracting the activity of PER
kinases CK1δ/ε in vivo. The extrahyperphosphorylated species of
PER seen in CA-treated cells were not observed in DN PP1 cells,
probably because PP1 activity was not disrupted as severely as byCA
treatment. Taken together, our data reveal that temporal phos-
phorylation of PER is determined by the balance between the op-
posing actions of CK1δ/ε and PP1.
Kinases other than CK1δ/ε may also play a role (28–32). When
we inhibited PP1/2AwithCA in theCK1δ/εmutant cells, PER1did
not reach the same hyperphosphorylated state as seen in WT cells
treated with CA (cf. Figs. 4E and 3C). However, hypophosphory-
lated forms of PER1 seemed to become a little more phosphory-
lated over time (Fig. 4E). PER2 was hyperphosphorylated in the
mutant cells treated with CA to a level similar to that in control
cells before CA treatment (Fig. 4E). This result suggests that PER1
and PER2 are phosphorylated by kinases other than CK1δ/ε, but
the phosphorylation is rapidly reversed by phosphatases. Phos-
phorylation by these kinases may target PER for proteasomal
degradation, as we had found that PER is degraded by the pro-
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Fig. 3. Phosphatase inhibition by calyculin A (CA) causes rapid hyper-
phosphorylationanddegradationof PER, anddisruption of circadian rhythms in
ﬁbroblasts and lung explants. (A) Circadian rhythms are abolished by CA
treatment at a high dose. Per2Luc ﬁbroblasts were treated with DMSO, OA, or
CA for 2 h at the ﬁrst peak of the bioluminescence rhythm, then washed and
returned to the Lumicycle. Per2Luc lung was treated with DMSO or CA for 2 h
near the second peak, then washed and returned to the Lumicycle. Red bar
indicates the timing of the treatment. (B) Circadian rhythms are shortened by
CA treatment at low doses in a dose-responsive manner. The cells were treated
with CA for 6 h at the ﬁrst peak and then measured for bioluminescence
rhythms. Because only one complete cyclewasobserved after theCA treatment,
period and amplitude of the one cycle were compared. (Upper) Comparison of
representative traces. (Lower) Periodand relative amplitude valuespresented as
mean ± SEM from a representative of several experiments. Sample number:
DMSO = 5; 1 nM = 5; 2 nM = 3; 3 nM = 5. P values were calculated by Student t
test between two groups. *P < 0.05; **P < 0.01. (C) Hyperphosphorylation
and rapid degradation of PER1/2 by CA treatment. Desynchronized Per2Luc
ﬁbroblasts were treated with DMSO or CA and harvested at the indicated
times. (D) Accelerated PER phosphorylation by CA treatment. Fibroblasts
were treated with cycloheximide for 10 h to remove existing PER, washed,
and treated with DMSO or CA. The arrow indicates a nonspeciﬁc band. (E) In
vitro kinase assay of in vivo PER:CK1δ/ε complexes. In vivo PER:CK1δ or ε
complexes were puriﬁed by immunoprecipitation with antibody to CK1δ or
CK1ε, and subjected to in vitro kinase reaction for 30 min. The resulting
samples were subjected to immunoblotting for PER1/2 and CK1δ/ε. Note that
CK1δ/ε were also phosphorylated by the kinase reaction (p-CK1δ/ε).
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teasome even in the absence of CK1δ/ε (Fig. 2B). Expression of
DN64PP1 in the mutant cells also induced hyperphosphorylation
of PER2, conﬁrming that PP1 is a major phosphatase for PER2
and opposes the non-CK1δ/ε kinases (Fig. 4F). Based on previous
in vitro studies, other CK1members, such as CK1α and CK1γ, may
be responsible for this mobility-shifting PER phosphorylation in
the CK1δ/ε mutant cells (28, 29). In our in vitro assay using tran-
siently expressed proteins in cultured cells, CK1α and γ can induce
mobility-shifting PER phosphorylation, though not as efﬁciently as
CK1ε (Fig. 4G); their lower activity is consistent with the ﬁnding
that their interaction with PER is signiﬁcantly weaker than in-
teraction between PER and CKIδ/ε (28, 29, 53). It is also possible
that PER phosphorylation under these conditions may be attrib-
uted to other kinases, such as CK2, GSK3β, and ERK2, previously
implicated as PER kinases by in vitro studies (29–32).
Discussion
The importance of PER kinases has long been recognized, and
previous work has shown that CK1δ/ε are important (14–18, 21,
23–25, 27, 54, 55), but our generation of CK1δ/ε-deﬁcient cells
enabled us to study the roles of these kinases with unprecedented
rigor. Although the previous studies suggested that CK1δ and
CK1ε are essential kinases for PER phosphorylation and a
functioning clock, our present study clearly establishes that
CK1δ/ε are redundant for PER phosphorylation. Additional
kinases such as CK1α/γ may also regulate PER phosphorylation
and stability, but the high afﬁnity of CK1δ/ε for PER (and pos-
sibly their abundance relative to other CK1s) would ensure that
their contribution to phosphorylation would outcompete that of
CK1α/γ. CK2 and GSK3β may also phosphorylate PER on im-
portant residues in vivo. However, we show that CK1δ/ε are ir-
replaceable for promoting nuclear entry/accumulation of PER,
which is a key event in the negative feedback loop.
We also reveal an interesting difference in regulation between
PER1 and PER2. In the absence of CK1δ/ε, PER1 (unlike
PER2) is stably phosphorylated to an intermediate level. If fur-
ther phosphorylation by CK1δ/ε requires this initial phosphory-
lation, then the priming kinase(s) may also be essential for the
circadian clock. The PER1 rhythm would be compromised
without the priming phosphorylation, and this could lead to a
complete disruption of the molecular oscillator, as seen in cells
with constitutively expressed PER1 (11).
Our data suggest that the gradual, progressive phosphoryla-
tion of PER proteins occurs because the rate of PER de-
phosphorylation is slower than that of phosphorylation. PER in
mammals is mainly dephosphorylated by PP1, whereas PP2A has
little effect. Our data are consistent with previous in vitro studies
showing that PP1 antagonizes CK1δ/ε activity (43, 56). Our
ﬁndings are also consistent with the presence in mammalian
PERs of PP1-binding motifs (R/K-V/I-x-F; Fig. S7B) (41, 57, 58).
This motif, commonly found in PP1-binding regulatory subunits,
suggests that direct binding between the PP1 catalytic subunit
and PER1/2 may occur. Our ﬁndings contrast with studies in
Drosophila, where PP2A (rather than PP1) is the clock-relevant
PER phosphatase (41, 42).
Because CK1δ/ε and PP1 activities do not oscillate (12, 56),
overall speed of PER phosphorylation—resulting from the rel-
ative activity between CK1 and PP1—would remain constant
over the circadian cycle. However, the relative activity can be
modulated by disrupting CK1δ/ε or PP1 activities pharmaco-
logically or genetically. If PP1 activity is disrupted (as by CA or
DN-PP1), then the excess CK1δ/ε activity enhances the speed of
PER phosphorylation, and the clock runs faster. However, if
CK1δ/ε activity is disrupted, PER phosphorylation slows down,
resulting in a slower oscillator (27, 54, 55). While our work was
under review, Schmutz et al. (39) showed that inhibition of PP1
activity slightly lengthened the period of bioluminescence and
behavioral rhythms. The difference in the effect of PP1 inhibition
may be due to different levels of inhibition and/or different
methods of inhibition. Because rhythms in PER phosphorylation
determine phase and period of the molecular oscillator and
circadian rhythms, our present study provides clear insights into
how the clock can be regulated by posttranslational regulation
of the critical clock component PER, and also provides well-
deﬁned targets for therapeutic intervention to treat circadian
clock disorders.
Materials and Methods
Animals, Cells, and Antibodies. All animals were maintained and used
according to the Florida State University Animal Care and Use Committee’s
guidelines. The CK1δﬂ/ﬂ;CK1εﬂ/ﬂ double-ﬂoxed mutant ﬁbroblasts were iso-
lated from the tails of double-ﬂoxed mutant mice described previously (27)
and immortalized as described previously (11). Cre was expressed in these
cells by an adenoviral vector (SI Materials and Methods). Deletion of both
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Fig. 4. PP1 is a major PER phosphatase and essential for rhythm generation. (A)
PP2Ac levels are dramatically reduced in α4 mutant ﬁbroblasts, but PER phos-
phorylation is intact. Cre (used for conditional deletionofﬂoxed α4)was activated
by addition of 4-hydroxytamoxifen (TM) to the medium. (B) Coimmunoprecipi-
tation of PER with PP1 catalytic subunit PP1c. (C) Shortened and compromised
bioluminescence rhythms in dominant negative PP1 (DN64 or DN95)-expressing
cells. Adenoviral DN64, DN95, or gfp was infected into Per2Luc ﬁbroblasts, and
expression of DN was initiated by doxycycline. The period (measured from the
ﬁrst two peaks) of the bioluminescence rhythms was 3–4 h shorter in DN-
expressing cells. GFP:n= 6; period (hr) = 23.9± 0.2; relative amplitude = 53.0± 3.3.
DN64: n = 4; period = 20.0 ± 0.1; amplitude = 15.4 ± 2.9. DN95: n = 4; period =
21.1 ± 0.1; amplitude = 26.5 ± 3.6. Values presented are mean ± SEM from
three experiments. (D) Hyperphosphorylation and rapid degradation of PER
induced by DN expression. Desynchronized cells were infected with adenovirus,
treated with doxycycline, and harvested at the indicated times. (E) PER2 phos-
phorylation after CA treatment in CK1δ/ε-deﬁcient cells. The mutant cells were
harvested at the indicated times after CA treatment. (F) PER2 phosphorylation
in the mutant cells with and without expression of DN64 (DNPP1). (G) PER
phosphorylation by CK1α/γ in vitro. The kinases and Per were cotransfected into
NIH 3T3 cells and harvested 48 h later. ε, CK1ε; α, CK1α; γ, CK1γ.
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CK1δ/ε genes was tolerated but induced slow growth in the immortalized
cells. The α4ﬂ p53−/−Cre-estrogen receptor (ER) mouse embryonic ﬁbroblasts
and anti-α4 antibody were kindly provided by Mei Kong and Craig
Thompson (University of Pennsylvania, Philadelphia). In these cells, Cre was
activated by the addition of 200 nM 4-hydroxytamoxifen (TM) to the me-
dium. Per2Luc ﬁbroblasts were described previously (4).
Generation of CK1δ/ε Double-Mutant Cells for Monitoring Bioluminescence
Rhythms and Immunoblotting. Double-ﬂoxed (CK1δﬂ/ﬂ; CK1εﬂ/ﬂ) ﬁbroblasts
were grown in DMEM supplemented with 10% FBS. The ﬁbroblasts were
infected with adenoviral gfp or cre in 100-mm dishes when the cells had
reached ∼70% conﬂuency, and the cultures were then split twice over ∼5 d.
At the third split, the cells were transferred into 35-mm dishes, infected with
adenoviral-Per2-Luc reporter and/or other adenovirus for 1 d, and set up for
measuring bioluminescence after a 2-h serum shock. For immunoblots, at
the third split the cells were transferred into 60-mm dishes and infected with
adenovirus for 1 d or treated with drugs before harvesting at speciﬁc times.
Lung tissue was incubated with adenovirus cre for 5 d and then infected
with the adenoviral Per2:Luc reporter. Period and amplitude in Figs. 2C,
3B, and 4C were calculated using the periodogram function in ClockLab
software. First four, one, and two peaks after drug treatment or serum
shock were considered for Figs. 2C, 3B, and 4C, respectively. P values were
calculated by Student t test between two groups (*P < 0.05; **P < 0.01;
***P < 0.001).
See SI Materials and Methods for additional information.
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